Taken together, these observations potentially explain how active PKCβII regulates its own gene expression25, 26, and also link SP1 and STAT3 into the pathobiology of CLL because high levels of VEGF are present in lymph nodes and bone marrow of CLL patients with late stage disease28. The gene discussed is VEGFA; the disease is B-cell chronic lymphocytic leukemia.